FDA has approved the first preparation for stimulation of growth of eyelashes.

Control on products and medicines of the USA (FDA) has resolved commercial release of the first preparation for intensifying of growth of eyelashes under the name «Latisse» company Allergan effectings. The medicine which is released under the prescription, will appear on sale cheap levitra mastercard already in the first quarter 2009, reports WebMD.
The preparation «Latisse» represents analogue of Prostaglandinums, let out in the form of 0,03 % of solution with an applicator. The phentermine mastercard preparation which it is necessary to put on a skin of an upper eyelid at the establishment of eyelashes, does their longer, dense and dark. At daily application «Latisse» once a day, before a sleep, the positive effect becomes already swept up in eight weeks, sires confirm.
In some cases the preparation can invoke such by-effects as reversible darkening of a skin of eyelids and irreciprocal - an iris order pyridium online now of the eye of eyes, and also conjunctiva reddening.
Cost of 30-day course of treatment «Latisse», presumably, will compound about 120 US dollars.
Earlier preparation was issued only in the form of ophthalmic drops under the name «Lumigan», designed for glaucoma treatment. Clinical researches have confirmed the "side-effect" of a preparation bound to stimulation of growth of eyelashes.